Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference
(Thomson Reuters ONE) -
GAITHERSBURG, Md., 2016-12-06 22:05 CET (GLOBE NEWSWIRE) -- Novavax, Inc.,
(Nasdaq:NVAX) today announced the Company will participate in the 4th Annual
Guggenheim Boston Healthcare Conference.
Conference details are as follows:
Date: Tuesday, December 13, 2016
Location: Intercontinental Boston Hotel, Boston, MA
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is available
on the Company's website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir(at)novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull(at)russopartnersllc.com
todd.davenport(at)russopartnersllc.com
212-845-4271
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 06.12.2016 - 22:05 Uhr
Sprache: Deutsch
News-ID 511279
Anzahl Zeichen: 1739
contact information:
Town:
Maryland
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 215 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Novavax, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
